Gunmen kill police officer assigned to protect polio workers in southwestern Pakistan
QUETTA, Pakistan — Gunmen shot and killed a police officer assigned to protect polio workers in southwestern Pakistan on Tuesday before fleeing the scene, police and officials said.
The attack occurred in Noshki, a district in Balochistan province, local police official Mohammad Hassan said, adding that the polio workers escaped unharmed in the attack.
The female health workers were administering oral polio vaccine drops to children inside a house when the assailants opened fire on the officer, Abdul Waheed, who died on the way to the hospital, Hassan said.
No one immediately claimed responsibility for the assault, but suspicion is likely to fall on separatist groups and Pakistani Taliban that have stepped up attacks on security forces and civilians in recent months.
Prime Minister Shehbaz Sharif and Interior Minister Mohsin Naqvi in separate statements denounced the assault and vowed stern action against those behind the attack, which came a day after Pakistan launched the nationwide campaign to vaccinate 45 million children from polio.
Pakistan and neighboring Afghanistan remain the only two countries where the spread of the wild polio virus hasn't been stopped, according to the World Health Organization. There are ongoing outbreaks of polio linked to the oral vaccine in 10 other countries, mostly in Africa.
Since January, Pakistan has reported 10 polio cases from various parts of the country despite the launch of immunization drives. Last year, the South Asian country witnessed a surge in polio cases, which jumped to 74, though it reported only one polio case in 2021.
Since the 1990s, more than 200 polio workers and the police assigned to protect them have been killed in attacks.
The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
5 hours ago
- CTV News
Sask. Virtual Health Hub launches new projects
WATCH: A born in Saskatchewan idea to transform access to healthcare is adding two new partners to its team. Members of the provincial and federal government, healthcare providers and First Nation leaders gathered at the Virtual Health Hub in Saskatoon on Friday to celebrate a milestone. 'Today we are announcing that Virtual Health Hub is joining CAN Health Network in launching two new commercialization projects with two leading Canadian Technology companies.' The partnership with CAN Health Network will allow improved access, equity and health outcomes for northern and Indigenous populations through collaboration and technology. Saskatchewan based Luxsonic and its Virtual Imaging Platform designed for radiologists to remotely view and interpret diagnostic imaging to support faster diagnoses. 'These projects give companies like ours the opportunity to prove our technology in real-world settings, build trust with healthcare providers and accelerate adoption across Canada,' said Mike Wesolowski, CEO and founder of Luxsonic. It's the company's second project with CAN Health Network. The other company added through this partnership is Nova Scotia based Virtual Hallway. The software enables physicians to consult with specialists for advice, ensuring patients get the right care faster. The company says with so many Saskatchewan residents living in rural areas but nearly all specialists living in cities, it can be hard on families and healthcare providers. 'Too often, those providers are left without timely input from a specialist,' said Dr. Luke Napier, chief medical officer at Virtual Hallway. 'And patients face long delays or long travel, or both. Virtual Hallway was built to change that. Our goals are simple and measurable, reduce unnecessary referrals and transfers, increase confidence in rural clinical decision making, and support the providers who are already doing so much.' The director of Virtual Health Hub says improvements in AI, telecommunications and robotics have allowed this shift toward a virtual delivery of healthcare. 'Since the pandemic, both the provider and the patient, that virtual care is a way of delivering healthcare,' said Dr. Ivar Mendez, director of Virtual Health Hub. 'And what I'm particularly proud of is that we are the leadership in the country, here in Saskatchewan. And Saskatchewan is the ideal place to scale up this technology.' A temporary hub location in downtown Saskatoon will be replaced by a permanent one on Whitecap Dakota Nation. 'There will be another announcement coming to announce the construction phase of the Virtual Health Hub, because that's going to be the next phase that's happening,' said Chief Darcy Bear, Whitecap Dakota Nation. 'It's not just about Indigenous healthcare, it is all about healthcare for all of Saskatchewan residents.' Bear says the new Virtual Health Hub is expected to be complete in early 2027.
Globe and Mail
5 hours ago
- Globe and Mail
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly 's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025
Globe and Mail
8 hours ago
- Globe and Mail
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians Newburyport, Massachusetts - Undergraduate students with dreams of becoming doctors now have a new opportunity to jumpstart their journey, thanks to the launch of the Dr. Guy Navarra Scholarship for Future Doctors. This $1,000 scholarship recognizes and supports one outstanding student preparing to enter the medical field—someone whose vision, heart, and dedication echo the values of its founder, Dr. Guy Navarra. The scholarship, now accepting applications, is designed for U.S.-based undergraduate students pursuing careers in medicine, pre-medical studies, or related health sciences. With the growing need for committed, forward-thinking professionals in healthcare, Dr. Guy Navarra aims to reward a student who not only excels academically but also holds a strong purpose for making an impact in tomorrow's healthcare system. To apply, students must submit a personal essay (500–800 words) in response to the following prompt: 'What inspires your journey into medicine, and how do you envision making a meaningful impact on the healthcare system of tomorrow?' Essays will be judged on clarity, authenticity, creativity, and alignment with the mission of Dr. Navarra's scholarship: to cultivate leadership, empathy, and transformation in the next generation of doctors. Dr. Guy Navarra brings a wealth of knowledge and inspiration to this initiative. With over 25 years of experience in internal medicine, geriatrics, and obesity medicine, he has held roles in clinical care, academic research, hospital leadership, and executive strategy. A graduate of Madrid's Complutense University, and later Yale and Harvard, Dr. Guy Navarra exemplifies what it means to blend global education with patient-centered care. His commitment to preventative medicine and ethical innovation has shaped programs, improved lives, and helped bridge gaps in the healthcare system. Currently serving as primary care physician for the Greater Newburyport area and Chief Medical Officer for MetTrimMD, Dr. Guy Navarra continues to lead by example—pioneering patient-first approaches to metabolic health and chronic disease management. Through this scholarship, he now turns his focus to supporting students who are following in his footsteps. 'The future of medicine depends not just on knowledge, but on heart and vision,' says Dr. Guy Navarra. 'This scholarship is a way to honor students who are already showing signs of leadership, passion, and the ability to think critically about where healthcare is headed.' Interested students should email their essay submission along with basic academic details—name, major, university, expected graduation year, and a short bio—to apply@ The deadline to apply is April 15, 2026, and the scholarship recipient will be publicly announced on May 15, 2026. The $1,000 award can be applied toward tuition, educational supplies, or other school-related expenses. It's not just a financial boost—it's a mark of recognition from a physician who believes deeply in mentoring the leaders of tomorrow. To learn more, visit the official scholarship site at Media Contact Company Name: Dr. Guy Navarra Scholarship Contact Person: Dr. Guy Navarra Email: Send Email City: Newburyport State: Massachusetts Country: United States Website:
